Assess the Effect of Daily Purgation therapy with small doses of medicine alongwith External panchakarma therapy in Diabetic peripheral neuropathy disease

Assessment of effect of Nitya virechana and Bahirparimarjana Chikitsa in Diabetic peripheral Neuropathy- An open labelled randomized comparative clinical trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041400

Enrollment

Registered

2022-03-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: G64- Other disorders of peripheral nervous system Health Condition 4: G63- Polyneuropathy in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Known case of type2 diabetes mellitus. 2)Presence of any classical symptoms- Burning sensation Pain Numbness Tingling sensation Insensitivity to hot or cold in feet. 3)Patients of both genders.

Exclusion criteria

Exclusion criteria: 1)Patients having any other associated clinical complication like cancer T.B Local skin infection wound Diabetic foot 2)Type1 diabetes. 3)Age below 30 years and age above 75years. 4)Pregnant and Lactating women.

Design outcomes

Primary

Measure	Time frame
1)Observing signs and symptoms of Patients in Diabetic peripheral neuropathy- Tingling sensation,Numbness,Burning sensation,Prickling sensation through symptoms grading score. 2)Modified toronto clinical neuropathy score(mTCNs) 3)Vibration and Thermal threshold test by Neuropathy analyser machine Biothesiometer. 4)Monofilament test 5)Laboratory invetigation- FBS,PP2BS LIPID PROFILE URINE INV. Haematological Vitamin B12(before treatment ) Timepoint: Before starting of Treatment and after 15 days of completion of treatment	—

Measure

Time frame

1)Observing signs and symptoms of Patients in Diabetic peripheral neuropathy- Tingling sensation,Numbness,Burning sensation,Prickling sensation through symptoms grading score. 2)Modified toronto clinical neuropathy score(mTCNs) 3)Vibration and Thermal threshold test by Neuropathy analyser machine Biothesiometer. 4)Monofilament test 5)Laboratory invetigation- FBS,PP2BS LIPID PROFILE URINE INV. Haematological Vitamin B12(before treatment ) Timepoint: Before starting of Treatment and after 15 days of completion of treatment

—

Secondary

Measure	Time frame
1)Changes in signs and symptoms of Diabetic peripheral neuropathy 2)changes in Modified toronto clinical neuropathy score 3)changes in Biothesiometer reading 4)changes in monofilament test 5)changes in FBS and PP2BS Timepoint: Patients will be assessed before treatment and after 15days completion of treatment	—

Countries

India

Contacts

Public ContactDrRahul SGandhi

Institute of Teaching and Research in Ayurveda,Jamnagar.

rsgandhi2003@yahoo.com9427451634

Outcome results